Bundle-forming pilus retraction enhances enteropathogenic Escherichia coli infectivity

Molecular Biology of the Cell

Volumn 22, Issue 14, 2011, Pages 2436-2447

  Zahavi, Eitan E ^a   Lieberman, Joshua A ^b   Donnenberg, Michael S ^b   Nitzan, Mor ^a   Baruch, Kobi ^c   Rosenshine, Ilan ^c   Turner, Jerrold R ^d   Melamed Book, Naomi ^a   Feinstein, Naomi ^a   Zlotkin Rivkin, Efrat ^a   Aroeti, Benjamin ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c HEBREW UNIVERSITY   (Israel)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; F ACTIN; PROTEIN BFPF; PROTEIN ESPF; PROTEIN TIR; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BACTERIUM PILUS; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; HOST CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; ARABINOSE; CACO-2 CELLS; CELL LINE; DIARRHEA, INFANTILE; DOGS; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FIMBRIAE, BACTERIAL; HELA CELLS; HUMANS; INFANT, NEWBORN; PHOSPHORYLATION; TYROSINE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 79960289464     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-01-0001     Document Type: Article

References (52)

1. Allen-Vercoe E, Waddell B, Livingstone S, Deans J, DeVinney R (2006). Enteropathogenic Escherichia coli Tir translocation and pedestal formation requires membrane cholesterol in the absence of bundle-forming pili. Cell Microbiol 8, 613-624. (Pubitemid 43372740)
2. Anantha RP, Stone KD, Donnenberg MS (1998). Role of BfpF, a member of the PilT family of putative nucleotide-binding proteins, in type IV pilus biogenesis and in interactions between enteropathogenic Escherichia coli and host cells. Infect Immun 66, 122-131.
3. Biais N, Higashi DL, Brujic J, So M, Sheetz MP (2010). Force-dependent polymorphism in type IV pili reveals hidden epitopes. Proc Natl Acad Sci USA 107, 11358-11363.
4. Bieber D, Ramer SW, Wu CY, Murray WJ, Tobe T, Fernandez R, Schoolnik GK (1998). Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. Science 280, 2114-2118. (Pubitemid 28366204)
5. Boettcher JP, Kirchner M, Churin Y, Kaushansky A, Pompaiah M, Thorn H, Brinkmann V, Macbeath G, Meyer TF (2010). Tyrosine-phosphorylated caveolin-1 blocks bacterial uptake by inducing Vav2-RhoA-mediated cytoskeletal rearrangements. PLoS Biol 8, 8e1000457.
6. Campellone KG (2010). Phosphoinositides influence pathogen surfing: EPEC rights the SHIP. Cell Host Microbe 7, 1-2.
7. Campellone KG, Leong JM (2003). Tails of two Tirs: actin pedestal formation by enteropathogenic E. coli and enterohemorrhagic E. coli O157:H7. Curr Opin Microbiol 6, 82-90. (Pubitemid 36258542)
8. Campellone KG, Leong JM (2005). Nck-independent actin assembly is mediated by two phosphorylated tyrosines within enteropathogenic Escherichia coli Tir. Mol Microbiol 56, 416-432. (Pubitemid 40516781)
9. Caron E, Crepin VF, Simpson N, Knutton S, Garmendia J, Frankel G (2006). Subversion of actin dynamics by EPEC and EHEC. Curr Opin Microbiol 9, 40-45. (Pubitemid 43184336)
10. Chen HD, Frankel G (2005). Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol Rev 29, 83-98.
11. Coureuil M et al. (2009). Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science 325, 83-87.
12. Donnenberg MS, Calderwood SB, Donohue-Rolfe A, Keusch GT, Kaper JB (1990). Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells. Infect Immun 58, 1565-1571. (Pubitemid 20176339)
13. Donnenberg MS, Giron JA, Nataro JP, Kaper JB (1992). A plasmid-encoded type IV fimbrial gene of enteropathogenic Escherichia coli associated with localized adherence. Mol Microbiol 6, 3427-3437.
14. Gauthier NC (2009). Bundle-forming pili from enteropathogenic Escherichia coli generate moderate forces. Biophys J 96, 519a.
15. Giron JA, Donnenberg MS, Martin WC, Jarvis KG, Kaper JB (1993). Distribution of the bundle-forming pilus structural gene (bfpA) among enteropathogenic Escherichia coli. J Infect Dis 168, 1037-1041. (Pubitemid 23282585)
16. Guttman JA, Finlay BB (2008). Subcellular alterations that lead to diarrhea during bacterial pathogenesis. Trends Microbiol 16, 535-542.
17. Guttman JA, Finlay BB (2009). Tight junctions as targets of infectious agents. Biochim Biophys Acta 1788, 832-841.
18. Guttman JA, Li Y, Wickham ME, Deng W, Vogl AW, Finlay BB (2006). Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell Microbiol 8, 634-645. (Pubitemid 43372742)
19. Hidalgo IJ, Raub TJ, Borchardt RT (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96, 736-749. (Pubitemid 19057595)
20. Howie HL, Glogauer M, So M (2005). The N. gonorrhoeae type IV pilus stimulates mechanosensitive pathways and cytoprotection through a pilT-dependent mechanism. PLoS Biol 3, e100.
21. Howie HL, Shiflett SL, So M (2008). Extracellular signal-regulated kinase activation by Neisseria gonorrhoeae downregulates epithelial cell proapoptotic proteins Bad and Bim. Infect Immun 76, 2715-2721.
22. Humphries RM, Donnenberg MS, Strecker J, Kitova E, Klassen JS, Cui L, Griener TP, Mulvey GL, Armstrong GD (2009). From alpha to beta: identification of amino acids required for the N-acetyllactosamine-specific lectin-like activity of bundlin. Mol Microbiol 72, 859-868.
23. Humphries RM, Griener TP, Vogt SL, Mulvey GL, Raivio T, Donnenberg MS, Kitov PI, Surette M, Armstrong GD (2010). N-acetyllactosamine-induced retraction of bundle-forming pili regulates virulence-associated gene expression in enteropathogenic Escherichia coli. Mol Microbiol 76, 1111-1126.
24. Hyland RM, Sun J, Griener TP, Mulvey GL, Klassen JS, Donnenberg MS, Armstrong GD (2008). The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin. Cell Microbiol 10, 177-187. (Pubitemid 350239065)
25. Iguchi A et al. (2009). Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J Bacteriol 191, 347-354.
26. Jerse AE, Yu J, Tall BD, Kaper JB (1990). A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 87, 7839-7843.
27. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB (1997). Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91, 511-520. (Pubitemid 27508240)
28. Kline KA, Falker S, Dahlberg S, Normark S, Henriques-Normark B (2009). Bacterial adhesins in host-microbe interactions. Cell Host Microbe 5, 580-592.
29. Lee SW, Higashi DL, Snyder A, Merz AJ, Potter L, So M (2005). PilT is required for PI(3,4,5)P3-mediated cross-talk between Neisseria gonorrhoeae and epithelial cells. Cell Microbiol 7, 1271-1284.
30. Maier B, Potter L, So M, Long CD, Seifert HS, Sheetz MP (2002). Single pilus motor forces exceed 100 pN. Proc Natl Acad Sci USA 99, 16012-16017. (Pubitemid 35462740)
31. Marcos LA, DuPont HL (2007). Advances in defining etiology and new therapeutic approaches in acute diarrhea. J Infect 55, 385-393. (Pubitemid 47611509)
32. McNamara BP, Koutsouris A, O'Connell CB, Nougayrede JP, Donnenberg MS, Hecht G (2001). Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J Clin Invest 107, 621-629. (Pubitemid 32205183)
33. Merz AJ, So M (2000). Interactions of pathogenic neisseriae with epithelial cell membranes. Annu Rev Cell Dev Biol 16, 423-457. (Pubitemid 32037513)
34. Merz AJ, So M, Sheetz MP (2000). Pilus retraction powers bacterial twitching motility. Nature 407, 98-102.
35. Milgotina EDM (2009). The bundlin-forming pilus and other Type IV pili. In: Pili and Flagella: Current Research and Future Trends, ed. KF Jarrell, Norfolk (UK): Caister Academic Press.
36. Mills E, Baruch K, Charpentier X, Kobi S, Rosenshine I (2008). Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe 3, 104-113. (Pubitemid 351201782)
37. Mota LJ, Journet L, Sorg I, Agrain C, Cornelis GR (2005). Bacterial injectisomes: needle length does matter. Science 307, 1278. (Pubitemid 40299971)
38. Nataro JP, Kaper JB (1998). Diarrheagenic Escherichia coli. Clin Microbiol Rev 11, 142-201. (Pubitemid 28046019)
39. Orzech E, Cohen S, Weiss A, Aroeti B (2000). Interactions between the exocytic and endocytic pathways in polarized Madin-Darby canine kidney cells. J Biol Chem 275, 15207-15219. (Pubitemid 30337245)
40. Philpott DJ, McKay DM, Sherman PM, Perdue MH (1996). Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Am J Physiol 270, G634-G645.
41. Rosenshine I, Ruschkowski S, Stein M, Reinscheid DJ, Mills SD, Finlay BB (1996). A pathogenic bacterium triggers epithelial signals to form a functional bacterial receptor that mediates actin pseudopod formation. EMBO J 15, 2613-2624. (Pubitemid 26176239)
42. Rothbaum R, McAdams AJ, Giannella R, Partin JC (1982). A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants. Gastroenterology 83, 441-454. (Pubitemid 12078232)
43. Rothbaum RJ, Partin JC, Saalfield K, McAdams AJ (1983). An ultrastructural study of enteropathogenic Escherichia coli infection in human infants. Ultrastruct Pathol 4, 291-304. (Pubitemid 13013840)
44. Saarikangas J, Zhao H, Lappalainen P (2010). Regulation of the actin cytoskeleton-plasma membrane interplay by phosphoinositides. Physiol Rev 90, 259-289.
45. Sason H, Milgrom M, Weiss AM, Melamed-Book N, Balla T, Grinstein S, Backert S, Rosenshine I, Aroeti B (2009). Enteropathogenic Escherichia coli subverts phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infection. Mol Biol Cell 20, 544-555.
46. Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, Turner JR (2006). Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119, 2095-2106. (Pubitemid 43904964)
47. Shifrin Y, Kirschner J, Geiger B, Rosenshine I (2002). Enteropathogenic Escherichia coli induces modification of the focal adhesions of infected host cells. Cell Microbiol 4, 235-243. (Pubitemid 34413842)
48. Simonovic I, Rosenberg J, Koutsouris A, Hecht G (2000). Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell Microbiol 2, 305-315. (Pubitemid 30612940)
49. Taylor CJ, Hart A, Batt RM, McDougall C, McLean L (1986). Ultrastructural and biochemical changes in human jejunal mucosa associated with enteropathogenic Escherichia coli (0111) infection. J Pediatr Gastroenterol Nutr 5, 70-73. (Pubitemid 17006369)
50. Taylor DN, Echeverria P (1993). Diarrhoeal disease: current concepts and future challenges. Molecular biological approaches to the epidemiology of diarrhoeal diseases in developing countries. Trans R Soc Trop Med Hyg 87, Suppl 33-5.
51. Trabulsi LR, Keller R, Tardelli Gomes TA (2002). Typical and atypical enteropathogenic Escherichia coli. Emerg Infect Dis 8, 508-513. (Pubitemid 34533329)
52. Turner JR, Rill BK, Carlson SL, Carnes D, Kerner R, Mrsny RJ, Madara JL (1997). Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol 273, C1378-C1385.